InsidersTradesSigma
Devyser Diagnostics AB: insider trades · Finland · FIN-FSA
FI:devyser-diagnostics-ab-158200SE0016588867FI·FIN-FSAMcap 1.5Bn€Healthcare
Discover the full directors' dealings record of Devyser Diagnostics AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Devyser Diagnostics AB has recorded 5 public disclosures. Market capitalisation: €1.5bn. The latest transaction was filed on 20 March 2026 — Purchase. Among the most active insiders: Mia Arnhult. All data is openly available.
5
Insider Decl.
0
Thresholds
€99,264
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
90.10 €
Analyst consensus
3 analystsStrong buy
141.55 €Target 152.94 €(+70%)165.81 €
Income statement
Revenue250.5 M€
Gross profit201.9 M€81% margin
Net income−8.4 M€5.8% margin
Valuation
PER (trailing)100.1x
PER (forward)28.5x
P/Book4.2x
Beta0.82
Balance sheet & cash
Market cap1.51 Bn€
Total debt51.9 M€
Free Cash Flow−62.0 M€
Debt / Equity14%
Profitability & ownership
ROE4.4%
ROA4.7%
% insiders30.0%
% institutions47.7%
Last declaration on 20 March 2026
Declarations5 total
Executives●Purchase16FIN-FSA
€3,574500 shares@ €7.14810.0002% mcap0.5% of flow
Aktie
FI:A003X205-1·
Ideal exit: 15 Dec 2026 (T+270)
Executives●Other17FIN-FSA
€90,7789,802 shares@ €9.26120.0060% mcap12.4% of flow
Aktie
FI:A003W323-1·
Executives●Purchase36FIN-FSA
€28,3733,000 shares@ €9.45770.0019% mcap100.0% of flow
Aktie
FI:A003W255-1·
Ideal exit: 15 Nov 2026 (T+270)
Executives●Other36FIN-FSA
€569,43241,596 shares@ €13.68960.038% mcap77.9% of flow
Aktie
FI:A003S223-1·
Executives●Purchase21FIN-FSA
€67,3177,000 shares@ €9.61670.0045% mcap9.2% of flow
Aktie
FI:A003M659-1·
Ideal exit: 9 Dec 2025 (T+270)
5 of 5 declarations